1. Home
  2. GEF vs EWTX Comparison

GEF vs EWTX Comparison

Compare GEF & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greif Inc.

GEF

Greif Inc.

HOLD

Current Price

$82.02

Market Cap

4.7B

Sector

N/A

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$39.39

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEF
EWTX
Founded
1877
2017
Country
United States
United States
Employees
15660
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.1B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
GEF
EWTX
Price
$82.02
$39.39
Analyst Decision
Hold
Buy
Analyst Count
6
14
Target Price
★ $88.00
$52.62
AVG Volume (30 Days)
328.8K
★ 1.3M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 2.98%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $5,448,100,000.00
N/A
Revenue This Year
$0.78
N/A
Revenue Next Year
$2.79
N/A
P/E Ratio
$4.09
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$55.75
$15.23
52 Week High
$90.57
$48.51

Technical Indicators

Market Signals
Indicator
GEF
EWTX
Relative Strength Index (RSI) 51.79 46.70
Support Level $81.98 $37.33
Resistance Level $85.08 $41.22
Average True Range (ATR) 2.31 1.74
MACD 0.33 0.25
Stochastic Oscillator 43.91 65.99

Price Performance

Historical Comparison
GEF
EWTX

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: